Masimo Corporation (0JZ2.L)
USD 153.86
(-0.49%)
USD 153.86
(-0.49%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 804 Million USD | 4.08% |
| 2022 | 772.5 Million USD | 208.41% |
| 2021 | -712.58 Million USD | -17.38% |
| 2020 | -607.09 Million USD | -10.95% |
| 2019 | -547.2 Million USD | 0.96% |
| 2018 | -552.49 Million USD | -75.23% |
| 2017 | -315.3 Million USD | -3.07% |
| 2016 | -305.89 Million USD | -679.05% |
| 2015 | 52.82 Million USD | 721.29% |
| 2014 | -8.5 Million USD | 91.06% |
| 2013 | -95.13 Million USD | -36.95% |
| 2012 | -69.46 Million USD | 46.47% |
| 2011 | -129.76 Million USD | -47.23% |
| 2010 | -88.13 Million USD | 33.14% |
| 2009 | -131.82 Million USD | 9.89% |
| 2008 | -146.28 Million USD | -122.69% |
| 2007 | -65.69 Million USD | -91.3% |
| 2006 | -34.34 Million USD | -330.66% |
| 2005 | 14.88 Million USD | 0.0% |
| 2003 | -11.12 Million USD | -42.76% |
| 2002 | -7.79 Million USD | 0.0% |
| 1999 | -12.1 Million USD | -19.8% |
| 1998 | -10.1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 731 Million USD | -9.45% |
| 2024 Q1 | 807.3 Million USD | 0.41% |
| 2024 Q3 | 574.7 Million USD | -3.91% |
| 2023 Q1 | 723.4 Million USD | -12.41% |
| 2023 Q2 | 738.1 Million USD | 2.03% |
| 2023 Q4 | 804 Million USD | 2.33% |
| 2023 Q3 | 785.7 Million USD | 6.45% |
| 2023 FY | 804 Million USD | 4.08% |
| 2022 Q4 | 825.9 Million USD | 8.07% |
| 2022 Q3 | 764.2 Million USD | 4.02% |
| 2022 Q1 | -681.2 Million USD | 4.4% |
| 2022 Q2 | 734.7 Million USD | 207.85% |
| 2022 FY | 772.5 Million USD | 208.41% |
| 2021 Q2 | -540.76 Million USD | -4.7% |
| 2021 Q3 | -618.73 Million USD | -14.42% |
| 2021 Q1 | -516.5 Million USD | 14.92% |
| 2021 Q4 | -712.58 Million USD | -15.17% |
| 2021 FY | -712.58 Million USD | -17.38% |
| 2020 FY | -607.09 Million USD | -10.95% |
| 2020 Q2 | -604.72 Million USD | -4.52% |
| 2020 Q3 | -640.49 Million USD | -5.92% |
| 2020 Q4 | -607.09 Million USD | 5.21% |
| 2020 Q1 | -578.59 Million USD | -5.74% |
| 2019 Q4 | -547.2 Million USD | -11.17% |
| 2019 FY | -547.2 Million USD | 0.96% |
| 2019 Q3 | -492.22 Million USD | -26.93% |
| 2019 Q2 | -387.79 Million USD | 0.93% |
| 2019 Q1 | -391.44 Million USD | 29.15% |
| 2018 FY | -552.49 Million USD | -75.23% |
| 2018 Q4 | -552.49 Million USD | -11.96% |
| 2018 Q1 | -369.49 Million USD | -17.19% |
| 2018 Q2 | -429.64 Million USD | -16.28% |
| 2018 Q3 | -493.48 Million USD | -14.86% |
| 2017 Q2 | -331.44 Million USD | 3.6% |
| 2017 Q1 | -343.82 Million USD | -12.4% |
| 2017 FY | -315.3 Million USD | -3.07% |
| 2017 Q4 | -315.3 Million USD | -8.75% |
| 2017 Q3 | -289.94 Million USD | 12.52% |
| 2016 Q3 | 26.51 Million USD | -55.08% |
| 2016 Q2 | 59.02 Million USD | -30.71% |
| 2016 FY | -305.89 Million USD | -679.05% |
| 2016 Q1 | 85.17 Million USD | 61.24% |
| 2016 Q4 | -305.89 Million USD | -1253.81% |
| 2015 Q4 | 52.82 Million USD | -39.0% |
| 2015 Q1 | -10.52 Million USD | -23.82% |
| 2015 FY | 52.82 Million USD | 721.29% |
| 2015 Q2 | 58.28 Million USD | 653.64% |
| 2015 Q3 | 86.59 Million USD | 48.57% |
| 2014 Q3 | 6.24 Million USD | 128.57% |
| 2014 Q1 | -117.27 Million USD | -23.27% |
| 2014 FY | -8.5 Million USD | 91.06% |
| 2014 Q2 | -21.85 Million USD | 81.37% |
| 2014 Q4 | -8.5 Million USD | -236.2% |
| 2013 FY | -95.13 Million USD | -36.95% |
| 2013 Q3 | -91.36 Million USD | -17.53% |
| 2013 Q2 | -77.73 Million USD | 4.3% |
| 2013 Q4 | -95.13 Million USD | -4.12% |
| 2013 Q1 | -81.22 Million USD | -16.93% |
| 2012 Q1 | -128.73 Million USD | 0.79% |
| 2012 Q2 | -121.42 Million USD | 5.68% |
| 2012 Q3 | -112.85 Million USD | 7.05% |
| 2012 Q4 | -69.46 Million USD | 38.45% |
| 2012 FY | -69.46 Million USD | 46.47% |
| 2011 FY | -129.76 Million USD | -47.23% |
| 2011 Q4 | -129.76 Million USD | 9.29% |
| 2011 Q3 | -143.05 Million USD | -13.95% |
| 2011 Q2 | -125.54 Million USD | -19.06% |
| 2011 Q1 | -105.44 Million USD | -19.65% |
| 2010 Q1 | -35.93 Million USD | 72.74% |
| 2010 FY | -88.13 Million USD | 33.14% |
| 2010 Q2 | -110.76 Million USD | -208.23% |
| 2010 Q3 | -125.21 Million USD | -13.05% |
| 2010 Q4 | -88.13 Million USD | 29.62% |
| 2009 Q4 | -131.82 Million USD | 24.36% |
| 2009 FY | -131.82 Million USD | 9.89% |
| 2009 Q3 | -174.27 Million USD | -11.61% |
| 2009 Q1 | -151.7 Million USD | -3.7% |
| 2009 Q2 | -156.14 Million USD | -2.92% |
| 2008 Q4 | -146.28 Million USD | -20.05% |
| 2008 Q3 | -121.85 Million USD | -19.5% |
| 2008 Q2 | -101.97 Million USD | -20.09% |
| 2008 Q1 | -84.91 Million USD | -29.26% |
| 2008 FY | -146.28 Million USD | -122.69% |
| 2007 Q1 | 8.82 Million USD | 125.71% |
| 2007 FY | -65.69 Million USD | -91.3% |
| 2007 Q2 | 2.03 Million USD | -76.94% |
| 2007 Q3 | -54.48 Million USD | -2775.88% |
| 2007 Q4 | -65.69 Million USD | -20.58% |
| 2006 FY | -34.34 Million USD | -330.66% |
| 2006 Q4 | -34.34 Million USD | 0.0% |
| 2005 Q4 | 14.88 Million USD | 0.0% |
| 2005 FY | 14.88 Million USD | 0.0% |
| 2003 FY | -11.12 Million USD | -42.76% |
| 2002 FY | -7.79 Million USD | 0.0% |
| 1999 FY | -12.1 Million USD | -19.8% |
| 1998 FY | -10.1 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 1164.379% |
| Accuray Incorporated | 103.58 Million USD | -676.167% |
| Align Technology, Inc. | -840.47 Million USD | 195.661% |
| Elevance Health Inc. | 18.59 Billion USD | 95.676% |
| AxoGen, Inc. | 32.26 Million USD | -2391.787% |
| Boston Scientific Corporation | 8.23 Billion USD | 90.233% |
| CVS Health Corporation | 71.18 Billion USD | 98.871% |
| Cardinal Health, Inc. | 476 Million USD | -68.908% |
| Centene Corporation | 506 Million USD | -58.893% |
| DaVita Inc. | 10.65 Billion USD | 92.452% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 98.035% |
| Hologic, Inc. | 374.4 Million USD | -114.744% |
| Humana Inc. | 5.51 Billion USD | 85.432% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -62.77% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 85.159% |
| McKesson Corporation | 889 Million USD | 9.561% |
| Patterson Companies, Inc. | 648.47 Million USD | -23.983% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 82.832% |
| ResMed Inc. | 635.57 Million USD | -26.5% |
| Henry Schein, Inc. | 2.57 Billion USD | 68.716% |
| Teladoc Health, Inc. | 468.6 Million USD | -71.574% |
| Universal Health Services, Inc. | 5.24 Billion USD | 84.678% |
| Veeva Systems Inc. | -647.71 Million USD | 224.129% |
| Baxter International Inc. | 11.16 Billion USD | 92.8% |
| Becton, Dickinson and Company | 14.46 Billion USD | 94.441% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 130.222% |
| Danaher Corporation | 13.49 Billion USD | 94.041% |
| Stryker Corporation | 10.02 Billion USD | 91.979% |
| Medtronic plc | 23.67 Billion USD | 96.605% |